Foghorn Therapeutics Inc (FHTX) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Foghorn Therapeutics Inc   (NASDAQ: FHTX)


Foghorn Therapeutics Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Foghorn Therapeutics Inc 's ROA in the third quarter of 2026?
Foghorn Therapeutics Inc achieved a return on average assets (ROA) of 4.63 % in its third quarter of 2026, this is above FHTX's average return on assets of -29.75%.
Foghorn Therapeutics Inc assets over the 12 months ending in its third quarter of 2026 are valued at $204 million

ROA has improved compared to -31.17% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 431 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3755, from total ROA ranking in the second quarter of 2026 at 4363.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change -6.84 % -10.1 % -14.12 % -23.98 % -27.64 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 9 -65 -75 -74 -72
Return On Assets (TTM) 4.63 % -31.17 % -35.39 % -33.46 % -30.35 %
FHTX's Total Ranking # 3755 # 4363 # 3787 # 3772 # 3822
Total Assets (TTM) in million 191 203 222 198 205
Seq. Total Assets Change -6.12 % -8.45 % 12.15 % -3.35 % -9.4 %
Seq. Net Income Change - - - - -

FHTX's 5 Years Annual ROA >> Back to FHTX Management Effectiveness >> Compare FHTX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 167
Sector # 432
Overall # 3643

Return On Assets Statistics
High Average Low
-22.04 %
-29.75 %
-42.24 %
(Jun 30 2021)   (Sep 30 2021)





Financial Statements
Foghorn Therapeutics Inc 's Assets $ 191 million FHTX's Balance sheet
Foghorn Therapeutics Inc 's Income $ 58 million Quarterly FHTX's Income Statement
FHTX's Income by Division See FHTX's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -23.98 % 2.12 % -30.92 % -23.13 % 125.39 %
Total Assets in million 198 261 255 369 481
Y / Y Net Income Change - - - - -
Net Income in million -74 -87 -98 -109 -101
Annual Return On Assets -37.5 % -33.24 % -38.57 % -29.48 % -21.08 %

FHTX's 5 Years Annual ROA >> Back to FHTX Management Effectiveness >> Compare FHTX ROA to its Competitors



More Return On Assets Ratios
FHTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FHTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FHTX's Competitors
Subscribers only: Roa for Foghorn Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for FHTX's Customers

You may also want to know
FHTX's Roi FHTX's Inventory Turnover Ratio FHTX's Growth Rates FHTX's Dividend Comparisons
FHTX's Profitability Ratios FHTX's Asset Turnover Ratio FHTX's Dividend Growth
FHTX's Roe FHTX's Valuation Ratios FHTX's Financial Strength Ratios FHTX's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Kiniksa Pharmaceuticals International Plc  12.64 %
Alpha Pro Tech Ltd   12.46 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Sanuwave Health Inc   9.05 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %
Johnson and Johnson  8.06 %
Pacific Health Care Organization Inc  7.83 %
Boston Scientific Corporation  7.82 %
Ani Pharmaceuticals Inc  7.77 %
Stryker Corp  7.66 %
Abbvie Inc   7.48 %
Ensign Group Inc  7.00 %
Pediatrix Medical Group Inc   6.99 %

Date modified: 2026-11-10T06:11:21+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.